Clinical trial
Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer
NCT00403221 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00403221 |
|---|---|
| Title | Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer |
| Official title | A Phase I Study of In-Situ, Neoadjuvant, Pre-Radical Prostatectomy RTVP-1 Gene Therapy in Patients With Locally Advanced Adenocarcinoma of the Prostate (SPORE) |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms |
| Intervention type | Genetic |
| Interventions | RTVP-1 Gene |
| Enrollment | 19 |
| Start date | Aug 1, 2006 |
| Primary completion | Apr 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Nov 23, 2006 |
| Last update posted | Feb 10, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: